Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 14, 2022 11:10 ET | Source: BTG Specialty Pharmaceuticals

SERB receives EU approval for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

London, Jan. 14, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals today announced that the European Commission has granted marketing authorisation for Voraxaze® (glucarpidase) to...
December 02, 2021 03:45 ET | Source: BTG Specialty Pharmaceuticals

Se presenta la primera evidencia de toxicidad relacionada con el metotrexato en dosis elevadas en España durante la Virtual ISPOR Europe 2021

COPENHAGUE, Dinamarca, Dec. 02, 2021 (GLOBE NEWSWIRE) -- La primera evidencia de la toxicidad relacionada con el metotrexato en dosis elevadas (HDMTX) en España se expuso hoy en la Virtual ISPOR...
December 01, 2021 02:00 ET | Source: BTG Specialty Pharmaceuticals

First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021

COPENHAGEN, Denmark, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The first evidence of high dose methotrexate related toxicity (HDMTX) in Spain was presented today at Virtual ISPOR Europe 2021, a global...
April 20, 2021 11:58 ET | Source: BTG Specialty Pharmaceuticals

BTG Specialty Pharmaceuticals Calls on Consumers and Retailers to Consider the Facts About Venom Extractors

WEST CONSHOHOCKEN, Pa., April 20, 2021 (GLOBE NEWSWIRE) -- To prepare for snakebite season, BTG Specialty Pharmaceuticals, a maker of critical care medicines, calls on outdoor enthusiasts to throw...

keyboard_arrow_left Previous Page